Discovery of novel osthole derivatives as potential anti-breast cancer treatment

被引:64
|
作者
You, Lisha [1 ]
An, Rui [1 ]
Wang, Xinhong [1 ]
Li, Yimin [1 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Sch Tradit Chinese Pharm, Shanghai 201203, Peoples R China
关键词
Osthole; Antitumor; Breast cancer; Natural product; Structure modification; COUMARIN DERIVATIVES; PREVENTION;
D O I
10.1016/j.bmcl.2010.10.027
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Osthole, an ingredient of Traditional Chinese Medicine (TCM) from natural product Cnidium monnieri (L.) Cusson, was used as a lead compound for structural modification. A series of osthole derivatives bearing aryl substituents at 3-position of coumarin, has been prepared and evaluated for their growth inhibitory activity against human breast cancer cell lines MCF-7 and MDA-MB-231. Interestingly, some derivatives exhibited good inhibition, among them compound 8e was found to be the most potent compound with IC50 values of 0.24 mu M, 0.31 mu M against MCF-7 and MDA-MB-231, respectively, which was improved more than 100-folds compared with its parent compound osthole. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7426 / 7428
页数:3
相关论文
共 50 条
  • [41] SYNTHESIS AND DESIGN OF NEW BROMOQUINAZOLINE DERIVATIVES WITH ANTI-BREAST CANCER ACTIVITY
    Ahmed, Marwa F.
    Jaiash, Dareen
    Belal, Amany
    ACTA POLONIAE PHARMACEUTICA, 2017, 74 (05): : 1437 - 1445
  • [42] Synthesis of Novel β-Keto-Enol Derivatives Tethered Pyrazole, Pyridine and Furan as New Potential Antifungal and Anti-Breast Cancer Agents
    Radi, Smaail
    Tighadouini, Said
    Feron, Olivier
    Riant, Olivier
    Bouakka, Mohammed
    Benabbes, Redouane
    Mabkhot, Yahia N.
    MOLECULES, 2015, 20 (11): : 20186 - 20194
  • [43] Design, synthesis, in silico, and pharmacological evaluation of novel quinoline derivatives containing substituted piperazine moieties as potential anti-breast cancer agents
    Priya, Muthiah Gnana Ruba
    Solomon, Viswas Raja
    Hemavathy, Nagarajan
    Jeyakanthan, Jeyaraman
    Kumar, Dileep
    Mahesh, Jahnavi
    RESULTS IN CHEMISTRY, 2024, 7
  • [44] Cytotoxicity and gene expression profiles of novel synthesized steroid derivatives as chemotherapeutic anti-breast cancer agents
    Elmegeed, Gamal A.
    Khalil, Wagdy K. B.
    Mohareb, Rafat M.
    Ahmed, Hanaa H.
    Abd-Elhalim, Mervat M.
    Elsayed, Ghada H.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (22) : 6860 - 6872
  • [45] Anti-breast cancer activity of some novel 1,2-dihydropyridine, thiophene and thiazole derivatives
    Al-Said, Mansour S.
    Bashandy, Mahmoud S.
    Al-Qasoumi, Saleh I.
    Ghorab, Mostafa M.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (01) : 137 - 141
  • [46] Comprehensive exploration of novel imidazopyrimidine derivatives: Design, synthesis, computational assessment, and anti-breast cancer activity
    Patel, Sagarkumar
    Pulugu, Priyanka
    Das, Rudradip
    Chowdhury, Moumita Ghosh
    Chatterjee, Deep Rohan
    Srivastava, Akshay
    Shard, Amit
    JOURNAL OF MOLECULAR STRUCTURE, 2025, 1326
  • [47] Synthesis and in vitro anti-breast cancer activity of some novel 1,5-benzothiazepine derivatives
    Ameta, K. L.
    Rathore, Nitu S.
    Kumar, Biresh
    JOURNAL OF THE SERBIAN CHEMICAL SOCIETY, 2012, 77 (06) : 725 - 731
  • [48] Computational evaluation of some compounds as potential anti-breast cancer agents
    Idris, Momohjimoh Ovaku
    Abechi, Stephen Eyije
    Shallangwa, Gideon Adamu
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 7 (01)
  • [49] Computational evaluation of some compounds as potential anti-breast cancer agents
    Momohjimoh Ovaku Idris
    Stephen Eyije Abechi
    Gideon Adamu Shallangwa
    Future Journal of Pharmaceutical Sciences, 7
  • [50] Discovery of novel pyrazolo[1,5-a]pyrimidine derivatives as selective ROCK2 inhibitors with anti-breast cancer migration and invasion activities
    Cao, Zhi
    Wei, Xiujian
    Xing, Shuming
    Zhang, Jiahao
    Wang, Shuqi
    Yue, Lingfeng
    Zhang, Jiahe
    Jiang, Nan
    Zhai, Xin
    BIOORGANIC CHEMISTRY, 2024, 151